Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Mol Cell Biochem ; 325(1-2): 25-40, 2009 May.
Article in English | MEDLINE | ID: mdl-19139974

ABSTRACT

The plasma (P), VLDL (V) triglyceride and apoB (B) clearance rates were measured both as 'mass' clearance (k (1)) and 'within the particle' clearance in three patient groups (E33, E23 and E34 phenotypes) at heparin-induced lipolysis in vivo. The lipid (C)- and apoE (E)-specific lipoprotein profiles both before and after heparin were followed by capillary isotachophoresis. The displacement of apoE by exogenous apoC-III at plasma titration in vitro was measured as well. The phenotype-sensitive lipoprotein networks were constructed based on an established set of metabolic rules. The k (1)(V) values did not differ between the three groups, but the lower k (1)(P) values showed significant differences. The k (1)(P) values for E33 and E23 groups were twofold higher compared to E34. A twofold increase in the rate constant for VLDL triglyceride clearance within the particle in E34 group compared to E23 reflected the inhibition of lipolysis by apoE2. For E33 group, (i) the k (1)(V) value was negatively correlated to the size of non-displaceable apoE pool in 2E lipoprotein and to the maximal apoE sorbtion capacity for 2E and 3E lipoproteins; (ii) the k (1)(P) value was not associated to the apoE binding parameters; (iii) the k (1)(V) value was positively correlated to the 4C level and the magnitude of apoC-III removal from VLDL particle; (iv) the k (1)(P) value was positively correlated to the content of apoE, while negatively with apoC-III, in VLDL remnants. For E34 group, the k (1)(V) value was positively correlated to 11C and 1-7C pool levels. Lipolysis- and receptor-mediated TG runways seem to be mostly balanced in E33 group, and VLDL TG clearance may be controlled by HDL through apoE dissociation from VLDLs and apolipoprotein accumulation within 'fast' HDLs at lipolysis.


Subject(s)
Apolipoprotein C-III/metabolism , Apolipoproteins E/metabolism , Electrophoresis/methods , Triglycerides/metabolism , Humans , Lipolysis , Phenotype
2.
Mol Cell Biochem ; 325(1-2): 41-51, 2009 May.
Article in English | MEDLINE | ID: mdl-19139973

ABSTRACT

Sixteen patients differing widely in plasma triglyceride content were divided into three groups by their apolipoprotein E (apoE) phenotype-E33 homozygotes, E23, and E34 heterozygotes. The plasma lipid and apoE distribution between individual lipoproteins was followed by capillary isotachophoresis (CITP) of plasma samples pre-stained with lipid fluorescent probe NBD-C6-ceramide and by fluorescein-labeled apoE, respectively. Among 12 peaks visualized by ceramide staining, an individual peak with very low density lipoproteins (VLDL) was identified. The VLDL cholesterol and apoE content determined by CITP directly in whole plasma were significantly related to their content as determined by conventional analysis with isolated VLDL. The ceramide distribution among lipoprotein pools was insensitive to apoE phenotype (49-53 : 7-11 : 39-43% for HDL, VLDL, and IDL/LDL, respectively) while the preferential binding of apoE to VLDL was observed in E34 patients compared to E33 (62 : 19 : 20 vs. 70 : 9 : 22%). In a study of apoE/F displacement from lipoproteins at plasma titration by apoC-III in vitro, apoE was found to bind more tightly to VLDL from E34 compared to E33 patients as evidenced by both the increased non-displaceable apoE pool, the increased VLDL sorbtion capacity for apoE, and the decreased displacement parameter in a "container" model of lipoprotein binding. Two different types of apoE package in a whole lipoprotein profile were observed. ApoE structure in a particular lipoprotein may underlie the phenotype-sensitive apoE distribution and apoC-III interference in hypertriglyceridemia.


Subject(s)
Apolipoproteins E/metabolism , Electrophoresis/methods , Lipoproteins/metabolism , Electrophoresis, Polyacrylamide Gel , Humans , Phenotype , Triglycerides/blood
SELECTION OF CITATIONS
SEARCH DETAIL